Versant Diagnostics
Versant Diagnostics is a PE-backed physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology services. It serves hospitals, health systems, and physician practices across the U.S. using the HALO AP digital pathology platform.
- Company typePrivate
- Founded2021
- HeadquartersOak Brook, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Versant Diagnostics does
Versant Diagnostics is a privately held, PE-backed physician services company focused on digital anatomic pathology. Founded in October 2021 through a partnership between Alliance Pathology Consultants, healthcare entrepreneurs Jim Billington and Brian Carr, and healthcare private equity firm Iron Path Capital, the company operates as a roll-up/acquisition platform that acquires and partners with independent pathology practices across the United States. It targets hospital systems and physician practices, providing capital infusion, operational support, and digital pathology infrastructure while preserving physician leadership at acquired practices.
The company's core technical asset is the deployment of HALO AP, an AI-powered digital pathology platform from Indica Labs, hosted on Amazon Web Services (AWS) and integrated with LIS/LIMS systems. Versant complements this with Aperio GT 450 DX scanners from Leica Biosystems for whole-slide imaging. The platform enables primary diagnosis, remote pathologist collaboration, second-opinion workflows, consultations, and clinical trial management, and is positioned as AI-agnostic, allowing flexible deployment of third-party AI tools. The company markets compliance with HIPAA, FDA 21 CFR Part 11, and GDPR. Versant operates regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast) and a dedicated dermatopathology sub-brand, Versant DermPath.
Versant's revenue model is professional services: it bills hospitals and physician practices for anatomic pathology diagnostic services delivered through its owned and partnered laboratory network. Go-to-market is sales-led enterprise field sales targeting hospital systems and specialty physician practices, with marketing concentrated on the company website, LinkedIn, press releases distributed via wire services, and participation in industry conferences such as Pathology Visions and dermatology society meetings. Capital for the acquisition strategy is provided by Iron Path Capital, with more than $100 million in growth capital deployed since founding. The network spans seven states (Illinois, Ohio, North Carolina, Virginia, Maine, Washington, Georgia) with pathologists licensed in 42 states.
Versant Diagnostics firmographics
Firmographics- Name
- Versant Diagnostics
- Legal name
- Versant Diagnostics
- Website
- https://versantdx.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Versant Diagnostics is a PE-backed physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology services. It serves hospitals, health systems, and physician practices across the U.S. using the HALO AP digital pathology platform.
- Ownership category
- akta.pro rank
Versant Diagnostics industry classification
Industry- Product category
- Anatomic Pathology Diagnostic Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic) (HLACALAD)
- akta.pro secondary industries
- Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE) (HLACALAJ), Image Exchange, Sharing & Patient/Provider Portals (DICOM/Web) (HLACALAI)
Keywords
Where Versant Diagnostics is headquartered
LocationHeadquarters
- HQ city
- Oak Brook
- HQ country
- United States
- HQ region
- North America
Offices9 records
Markets served
Versant Diagnostics business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pathology Diagnostic Services: Versant Diagnostics generates revenue by providing digital anatomic pathology diagnostic services to hospitals and physician practices through its network of acquired and partnered pathology groups. Revenue comes from professional pathology services billed to healthcare providers and payers.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
Versant Diagnostics product offering
Product offeringCore offering
Versant Diagnostics is a physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology diagnostic services to hospitals and physician practices. The company provides subspecialty pathology expertise across dermatopathology, gastroenterology, urology, hematology, and women's health, supported by the HALO AP AI-powered digital pathology platform from Indica Labs and Aperio GT 450 DX scanners from Leica Biosystems, enabling remote collaboration, primary diagnosis, and consultation across a network of laboratories in seven states.
Product overview
Versant Diagnostics is an independent physician services company that has built a platform-plus-network model for digital anatomic pathology. The core offering consists of the Versant Diagnostics platform providing capital, technology, and operational support to partner pathology practices, with Versant DermPath serving as the specialized dermatopathology sub-brand. The company deploys HALO AP® from Indica Labs as its primary digital pathology technology across a network of regional divisions (Midwest, MidAtlantic, Northeast, Northwest, Southeast). The platform enables pathologists to transition from conventional glass-slide microscopy to digital workflows, facilitating remote collaboration, consultations, and AI-powered diagnostic evaluation.
Differentiator
Problem solved
Functional benefit
Brands
- Versant DermPath: Dermatopathology-focused entity providing definitive skin specimen diagnoses by board-certified dermatopathologists with digital pathology capabilities.
Products and services
- Digital Anatomic Pathology Diagnostic Services Comprehensive digital anatomic pathology diagnostic services provided to hospitals and physician practices across dermatology, gastroenterology, urology, hematology, and women's health, delivered through a network of regional pathology groups with support from the HALO AP AI-powered digital pathology platform.
- Versant DermPath Specialized dermatopathology services providing definitive skin specimen diagnoses by board-certified dermatopathologists using digital pathology capabilities, coordinated across a nationwide network of dermatopathology practices.
- Surgical Pathology and Histology Services Surgical pathology, histology, and immunohistochemistry services delivered to hospitals and physician offices through partner pathology groups, supporting diagnosis of tissue specimens for patient care.
- Molecular Diagnostics and Cytology Services Cytology, flow cytometry, and molecular diagnostics services provided to hospitals and physician offices for advanced diagnostic evaluation of patient specimens.
- Subspecialty Pathology Consultations Subspecialty pathology consultations and second opinion services enabled by the HALO AP digital pathology platform, allowing referring providers to access board-certified subspecialty experts across dermatopathology, GI pathology, urology, hematopathology, and women's health regardless of geographic location.
Quantifiable outcome
- Digital pathology reduces diagnostic turnaround time and enables faster treatment initiation for patients
Companies that use Versant Diagnostics
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Versant Diagnostics technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration3 records
AI capability4 records
Feature4 records
Versant Diagnostics partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and supporting.
- SouthEastern PathologycoreVersant Diagnostics partnered with SouthEastern Pathology, a CAP accredited provider based in Rome, Georgia, extending the network into Georgia and neighboring states. SouthEastern Pathology has been a trusted provider for over 50 years. Dr. Frederick K. Swiger Jr. and Dr. Christopher Kligora continue in their current roles.
- Indica LabscoreVersant Diagnostics selected Indica Labs' HALO AP AI-powered digital pathology platform to deploy across its network of laboratories. The platform is hosted on AWS cloud and enables primary diagnosis, consultations, and AI integration. HALO AP is CE-IVDR marked for in-vitro diagnostic use in Europe.
- Leica BiosystemscoreVersant Diagnostics selected Aperio GT 450 DX scanners from Leica Biosystems for high-quality digital slide scanning. The scanners are part of the digital pathology deployment alongside HALO AP from Indica Labs.
- Amazon Web Services (AWS)supportingVersant Diagnostics uses Amazon Web Services (AWS) to host its HALO AP cloud deployment, fully managed by AWS certified HALO experts of Indica Labs' Cloud Services team.
- Avero DiagnosticscoreVersant Diagnostics partnered with Avero Diagnostics (formerly Northwest Pathology), based in Bellingham, Washington, to expand into the Pacific Northwest. Dr. Ryan Fortna serves as Regional Managing Director. Avero has been delivering innovative diagnostic solutions for decades and serves hospitals and clinics in the Pacific Northwest.
- Dahl-Chase Pathology Associates and Dahl-Chase Diagnostic ServicescoreVersant Diagnostics partnered with Dahl-Chase, based in Bangor, Maine, to expand into the Northeast. Dahl-Chase serves hospitals and physician offices with surgical pathology, histology, immunohistochemistry, cytology, flow cytometry, and molecular diagnostics services. Founded in 1971, Dahl-Chase has over 50 years of diagnostic history with 15 board-certified pathologists.
- PRW LaboratoriescoreVersant Diagnostics partnered with PRW Laboratories, a distinguished dermatopathology laboratory based in Charlottesville, Virginia, to expand dermatopathology services. This partnership builds out Versant's nationwide network of pathology specialties. Dr. David Rowe serves as Medical Director of PRW Laboratories.
- In-Office Pathology, LLC (IOP)coreVersant Diagnostics and IOP entered a joint collaboration agreement to increase access to pathologists and build pathology labs nationwide. Versant will offer pathology services to IOP's network of in-office labs, and IOP will build laboratories at select Versant specialty clinics and physician practices. IOP has over 90 high complexity testing installations in 30 states.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
Versant Diagnostics competitors and assessment
Company assessmentDirect peers
- Inform Diagnostics: Independent anatomic pathology services company offering subspecialty pathology across dermatopathology, GI, urology, and women's health. Directly comparable to Versant in customer base, service mix, and digital pathology focus; CEO Jim Billington previously co-founded Inform DX.
- NeoGenomics: Specialty oncology-focused clinical laboratory and anatomic pathology services provider with national reach. Comparable in business model (specialty pathology services to hospitals and physicians), scale, and digital pathology adoption via acquisition-led growth.
- Caris Life Sciences: Specialty molecular pathology and precision medicine company offering advanced anatomic and molecular diagnostics to hospitals and physicians. Versant's CIO Doug Olson previously served as CIO at Caris, indicating direct operational familiarity with the company's model.
Broad incumbents
- Quest Diagnostics: Largest independent clinical and anatomic pathology laboratory in the U.S. Provides diagnostic testing services across the full range of pathology, including anatomic pathology for hospitals and physicians. A broad incumbent against which Versant competes for hospital and physician referrals.
- Labcorp: Major clinical and anatomic pathology services provider with a national laboratory network. Several Versant senior executives previously held leadership roles at LabCorp, indicating direct familiarity with the competitor's go-to-market.
- Sonic Healthcare: Global medical diagnostics company with significant anatomic pathology operations in the U.S. (former Aurora Diagnostics network). Operates a multi-specialty anatomic pathology platform comparable to Versant's roll-up model.
- ARUP Laboratories: National reference and anatomic pathology laboratory affiliated with the University of Utah, offering highly subspecialized pathology services to hospitals and health systems. Comparable in subspecialty expertise and complex case mix.
Emerging players
- PathAI: AI-powered pathology technology company deploying machine learning tools for diagnostic and biopharma applications. Competes with Versant on the digital pathology software layer and may eventually partner with or disintermediate traditional pathology services providers.
- Proscia: Digital pathology software company offering enterprise imaging and AI-ready platforms for pathology labs. Comparable to the HALO AP deployment at Versant and represents an alternative technology vendor for similar roll-up strategies.
- Ibex Medical Analytics: AI-based pathology company with clinically deployed cancer detection algorithms. Represents a competitive threat to traditional pathology services in dermatopathology and other high-volume specialties, potentially eroding Versant's subspecialty value proposition.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Versant Diagnostics social profiles
Digital presenceVersant Diagnostics compliance and trust
Trust signalCompliance4 records
Versant Diagnostics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Versant Diagnostics leadership team
Management profileNumber of profiles
Profiles15 records
Versant Diagnostics subsidiaries and ownership
Company hierarchySubsidiaries5 records
Versant Diagnostics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Versant Diagnostics M&A and investment
M&A and investmentM&A2 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Versant Diagnostics
What does Versant Diagnostics do?
Versant Diagnostics is a physician services company that acquires and partners with independent pathology practices to deliver digital anatomic pathology diagnostic services to hospitals and physician practices. The company provides subspecialty pathology expertise across dermatopathology, gastroenterology, urology, hematology, and women's health, supported by the HALO AP AI-powered digital pathology platform from Indica Labs and Aperio GT 450 DX scanners from Leica Biosystems, enabling remote collaboration, primary diagnosis, and consultation across a network of laboratories in seven states.
Is Versant Diagnostics a public or private company?
Versant Diagnostics is a private company. It is classified as private equity controlled and is currently operating.
When was Versant Diagnostics founded?
Versant Diagnostics was founded in 2021. It employs 11 to 50 people.
Where is Versant Diagnostics based?
Versant Diagnostics is headquartered in Oak Brook, United States, in the North America region.
How does Versant Diagnostics make money?
One revenue line is on record: pathology Diagnostic Services.
Who are Versant Diagnostics's main competitors?
Direct peers on record are Inform Diagnostics, NeoGenomics and Caris Life Sciences. Broad incumbents are Quest Diagnostics, Labcorp, Sonic Healthcare and ARUP Laboratories. Emerging players are PathAI, Proscia and Ibex Medical Analytics.
Does Versant Diagnostics have an API?
No public API is recorded for Versant Diagnostics.
What industry is Versant Diagnostics in?
Versant Diagnostics's product category is Anatomic Pathology Diagnostic Services. Its primary akta.pro industry code is HLACALAD, Universal Viewers & Enterprise Imaging Access (Zero-footprint/Diagnostic), with a secondary code of HLACALAJ, Imaging Interoperability & Standards Enablement (DICOM/HL7/FHIR/IHE). Its NAICS code is 621511 and its SIC code is 8071.